Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/EBIT

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 5.359.7111.3063.7525.37

What is the latest EV/EBIT ratio of NATCO PHARMA ?

The latest EV/EBIT ratio of NATCO PHARMA is 5.35 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20255.35
Mar20249.71
Mar202311.30
Mar202263.75
Mar202125.37

How is EV/EBIT of NATCO PHARMA Trending?

Years EV/EBIT % Change
Mar2025 5.35
-44.90
Mar2024 9.71
-14.07
Mar2023 11.3
-82.27
Mar2022 63.75
151.28
Mar2021 25.37 -

Other Financial Ratios of NATCO PHARMA


Compare EV/EBIT ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,962.9 Cr 0.4% -6.9% -35.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.3% -7.3% -12.8% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr 0.8% -5.8% 4.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr 0.8% 3.7% 20.8% Stock Analytics
CIPLA ₹106,946.0 Cr 0.7% -11.2% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -1.4% -3.8% -1.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.4%

-6.9%

-35.3%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses